NASDAQ$ARAY

Accuray Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Accuray's financial performance for the third quarter of fiscal year 2020 was reported.

Accuray reported a solid third fiscal quarter with a 27% year-over-year increase in gross orders, reaching $106 million. Net revenue was $99.5 million and net income was $2.6 million, or $0.03 per share. The company ended the quarter with $91.6 million in cash, cash equivalents, and short-term restricted cash.

  • Gross orders increased 27% year-over-year to $106.0 million, including 11 orders from China.
  • Net orders of $76.7 million, an increase of 28% year-over-year.
  • Total backlog increased 15% year-over-year to $569.9 million.
  • Net revenue of $99.5 million, net income of $2.6 million, Adjusted EBITDA of $11.3 million

Headline financials

Total Revenue

$99.5M

Previous: $103M-3.6%
EPS (adj)

$0.03

Previous: -$0.01+400.0%
Gross Orders

$106M

Previous: $83.6M+26.8%
Adjusted EBITDA

$11.3M

Previous: $6.7M+68.7%
Capital Expenditures

-$2.76M

Previous: -$3.24M+14.6%
Free Cash Flow

-$139K

Previous: -$4.42M+96.9%
Net Income

$2.63M

Previous: -$1.18M+321.7%
Operating Income

$7.97M

Previous: $2.88M+176.6%
Gross Profit

$39.1M

Previous: $40.5M-3.3%
Cash & Equivalents

$89.7M

Previous: $62.5M+43.6%
Total Assets

$490M

Previous: $406M+20.6%
Stock-Based Comp

$2.02M

Previous: $2.88M-30.0%

Revenue & EPS history

Accuray · Revenue · Quarterly

$99.5M

Q3 2020-3.6%vs Q3 2019
Beat estimate in 6 of 14 quarters(43%)
ActualEstimate

Revenue by segment

Accuray · $99.5M total across 2 segments · Q3 2020

  • Services Revenue
    $54M-4.8%
  • Products Revenue
    $45.5M-2.0%

Forward guidance

Given the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry, Accuray believes it is prudent to withdraw its previous full fiscal year 2020 financial guidance regarding revenue and adjusted EBITDA.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-0.8%

Avg return

30 days after

47%

30 / 64 earnings

Positive

+49.7%

Q4 2024

Best reaction

-39.6%

Q3 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-39.6%-35.4%
Q2 2026-21.1%-27.6%-35.5%
Q1 2026-15.9%-19.3%-31.7%
Q3 2025-12.9%-16.1%-1.3%
Q2 2025+8.0%-8.0%-25.3%
Q1 2025+8.9%+3.1%+4.7%
Q4 2024+49.7%+62.1%+51.0%
Q3 2024-27.7%-16.0%-16.9%
Q2 2024-5.2%-11.9%-3.3%
Q1 2024-0.7%-7.8%-1.1%
Q4 2023-23.2%-23.2%-35.9%
Q3 2023+14.4%+24.9%+31.0%
Q2 2023+14.3%+18.3%+19.4%
Q1 2023+1.5%+4.5%+2.5%
Q4 2022+27.5%+43.5%+15.0%
Q3 2022-10.2%-15.2%-31.4%
Q2 2022-15.9%-11.0%-13.2%
Q1 2022+9.7%+1.9%-9.3%
Q4 2021-3.7%-10.7%-9.2%
Q3 2021-11.1%-14.7%-22.9%
Q2 2021+4.1%-4.3%-3.3%
Q1 2021+2.5%+16.9%+51.4%
Q4 2020-6.6%-10.6%-17.2%
Q3 2020+26.3%+21.1%+10.0%
Q2 2020+13.4%+3.2%-21.2%
Q1 2020-4.8%-11.4%+5.5%
Q4 2019-15.5%-16.1%-9.6%
Q3 2019+1.7%+4.3%-5.5%
Q2 2019+14.2%+15.5%+36.2%
Q1 2019+32.8%+40.5%+20.1%
Q4 2018+11.5%+14.9%+9.2%
Q3 2018-15.3%-8.9%-10.9%
Q2 2018+8.7%+9.7%-1.9%
Q1 2018+3.5%+14.1%+24.7%
Q4 2017+5.1%+5.1%+14.1%
Q3 2017-5.2%-12.5%-13.5%
Q2 2017+1.8%+1.8%-2.7%
Q1 2017-5.7%-7.5%+0.0%
Q4 2016-8.8%-3.1%-0.5%
Q3 2016-7.1%
Q2 2016-12.2%
Q1 2016+6.3%
Q4 2015+10.2%
Q3 2015-22.4%
Q2 2015+6.0%
Q1 2015-15.9%
Q4 2014+2.6%
Q3 2014-8.9%
Q2 2014+19.4%
Q1 2014+11.4%
Q4 2013+5.1%
Q3 2013+12.2%
Q2 2013-12.4%
Q1 2013+0.0%
Q4 2010-2.8%
Q4 2012-9.3%
Q3 2011-9.4%
Q3 2012-9.4%
Q2 2012+16.6%
Q2 2011+16.6%
Q4 2011-3.5%
Q1 2011-3.5%
Q1 2012-3.5%
Q3 2010-0.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro